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ABSTRACT
The fatty acids of plasma and erythrocytes from 
horses were analyzed before and after infection with equine 
infectious anemia virus (EIA). Changes in the composition of 
fatty acids were followed by gas-liquid chromatographic (GLC) 
analysis of the total lipid extract and the various lipid 
classes of both the plasma and erythrocytes.
The principle fatty acids detected in the plasma and 
erythrocytes were C16:0, C16:l, C18:0, C18:l, C18:2, C18:3, 
C22:0, and C24:0. Erythrocytes contained a higher percentage 
of long chain fatty acids than the plasma. The erythrocytes 
also contained C24 fatty acids of undetermined saturation 
which increased in concentration as EIA progressed. Lipid 
class analyses showed that these C24 fatty acids were present 
in the phospholipid (PL) and sterol ester (SE) fractions.
The erythrocytes had a ratio of saturated to unsatu­
rated fatty acids usually greater than 1, but in acute cases 
of EIA it decreased to 0.38. This decrease in the ratio was 
due to a marked increase in C24 unsaturated fatty acids.
The triglyceride (TG) fraction of the plasma which 
was observed on thin-layer chromatographic (TLC) plates under 
ultra-violet light exhibited progressive increases in concen­
tration in the plasma throughout the course of EIA.
The SE fraction of the plasma had the lowest ratio 
of saturated to unsaturated fatty acids. The ratio varied 
between 0.22 and 0.13 throughout the course of experimental 
EIA. The concentration of C18:2 ranged from 73.73 percent 
to 53.23 percent during the course of EIA. The concentra­
tion of the SE fraction decreased as determined on TLC 
plates as the disease progressed. In the preinoculation 
period the total lipid extract of the plasma contained 
approximately 40 percent of C18:2 which decreased through 
the course of the disease while the concentration of C18:l 
increased.
INTRODUCTION
Equine infectious anemia (EIA) has been recognized as 
a serious infectious disease of horses for almost 130 years 
(Dreguss and Lombard, 1954). The causative agent of the dis­
ease is a virus and is found in all tissues and fluids of the 
infected horse. Biting insects are the natural vectors of 
EIA; however, the most recent outbreaks of EIA have been 
attributed to the use of contaminated syringes and needles 
on horses.
The inability of researchers to find a suitable host 
other than the equine species presented numerous problems to 
investigators prior to the successful attempt by Kobayashi 
and Kono (1967) to propagate EIA virus in horse leukocyte 
cultures.
EIA is manifested in three forms: acute, subacute, and 
chronic. A hemolytic anemia is produced by EIA virus and 
there is a marked lipemia which develops as the disease pro­
gresses.
This investigation was initiated to study the possi­
bility that lipids were being produced during the course of 
the disease which could be responsible for the hemolytic 
anemia of EIA. In this investigation the total lipids of 
plasma and erythrocytes were extracted and analyzed by GLC.
The lipids of the plasma and erythrocytes were separated into
classes (PL, free fatty acid (FFA), TG, and SE) by TLC and 
analyzed by GLC. The changes in the fatty acids before in­
oculation and during the course of the disease are reported 
in this dissertation.
REVIEW OF LITERATURE
A. Early History of EIA
Equine infectious anemia is a viral disease of the 
equine species, and is mainly characterized by intermittent 
fever, marked depression, progressive weakness, loss of 
weight, marked ventral edema, congestion, icterus and anemia 
(Dreguss and Lombard, 1954).
First reported in Europe in 1843, EIA is considered 
today as a serious disease with a world-wide distribution. 
The first recognized cases of EIA in North America occurred 
in Canada about 1880. The disease has existed for about 75 
years in the United States. Natural outbreaks of EIA have 
been confined to relatively small areas and it has shown 
little tendency to spread. However, with modern transporta­
tion of animals, a potential danger of epizootics exists 
(Knowles, 1969).
The natural transmitting vectors of EIA are biting 
insects, but use of contaminated hypodermic syringes and 
needles is the most common method of transmitting EIA today.
Natural outbreaks of EIA are more prevalent in 
poorly-drained, low-lying sections, but it has also been 
found at high elevations on well-drained pastures. The 
incidence of the disease increases in the warm months of the
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year when biting insects are more abundant (Dreguss and 
Lombard, 1954).
Under natural conditions the virus appears to affect 
only the equine species. It may persist for life in a carrier 
state in animals who have recovered from the disease. The 
virus shows considerable resistance to disinfectants, heat, 
freezing, and drying (Stein and Mott, 1947).
The clinical disease syndrome manifests itself in 
three forms: acute, subacute and chronic. The acute form
is characterized by a sudden, rapid rise in body temperature 
which may reach 108° F. The temperature may either fluctuate 
or remain elevated until death. The more common, chronic 
form of EIA is characterized by intermittent attacks of fever, 
loss of weight, progressive weakness, marked depression and 
edema in the lower extremities (Dreguss and Lombard, 1954). 
Following the intermittent febrile attacks, the disease is 
generally progressive. Asymptomatic periods are often inter­
rupted by prolonged periods of clinical symptoms of EIA. A 
persistent viremia occurs in both asymptomatic carrier and 
during the active case of EIA.
B. Pathological Changes in EIA
1. Macroscopic Changes in Equine Species.
The macroscopic changes associated with EIA vary with 
the form of the disease. In acute and subacute cases, severe 
hemorrhages are visable on the serous and mucous membranes of 
the liver, heart, kidney and intestines. The intestines are
5sometimes filled with blood from hemorrhages of the intestinal 
mucosa. The liver is frequently enlarged as is the heart, 
kidney and spleen. The spleen is purple-red in color and 
has black homorrhagic foci scattered over the surface. It 
is swollen, congested, engorged with blood and the cut paren­
chyma tissue appears granular. Visceral lymph nodes are 
swollen and red due to hyperemia and hemorrhage. The liver 
appears cloudy and has an icteric appearance with numerous 
hemorrhagic foci. Kidneys are swollen, anemic and icteric 
(Knowles, 1969).
In the chronic form of EIA, the hyperemia and edema 
seen in the acute disease are reduced in the kidney, liver, 
spleen and lymph nodes. There is a proliferation of argyro- 
philic fibers. These organs undergo some atrophy. Splenic 
atrophy results in a thickened capsule with an elastic paren­
chyma. Splenic pulp becomes reddish and follicles are grossly 
recognizable. The trabeculae are very distinct on cut sur­
faces. The liver becomes atrophied in chronic cases and 
appears pale as the anemia becomes more pronounced. The 
kidney and lymph nodes undergo atrophy and become quite pale 
as time elapses. Active sites of hemorrhage are usually 
absent in chronic forms of EIA (Dreguss and Lombard, 1954).
2. Histological Changes in EIA.
The histopathological changes caused by the EIA virus 
varies with the form of disease syndrome? i.e., acute, subacute 
and chronic. Ishitani (1966) found characteristic histological 
lesions in the spleen, liver, lymph nodes, kidney, heart and
lungs in 120 EIA-infected horses. The primary lesions in the 
spleen in acute and subacute cases were marked degeneration 
and decreased numbers of lymph follicles, severe edema and 
engorgement with debris from destroyed red blood cells. The 
red pulp was hemorrhagic and congested with focal aggregation 
of basophilic round cells around the central and sheathed 
arteries. Yamamoto and Kono (1967) reported that the fine 
structure of the basophilic round cells closely resemble the 
plasma cells or their precursors.
In acute and subacute cases the visceral lymph nodes 
exhibited karyopyknotic and karyorrhectic degeneration of 
lymphocytes. The central core of the lymph follicles exhibited 
marked atrophy.
The kidney, lungs and adrenal glands in acute and 
subacute cases of EIA exhibit edema, cellular degeneration, 
hemorrhage and increased infiltration of histocytic cells.
The bone marrow showed massive hemorrhage in the acute and 
subacute forms of the disease. Yamamoto and Kono (1967) did 
not consider hemorrhage to be the chief pathological change 
in the bone marrow, but believed that the change in the 
density and extent of the bone marrow was the main area of 
pathology.
In chronic cases of EIA the major lesions are found 
in the liver. The histopathological changes are characterized 
by small round cell infiltration along the sinusoids and slight 
activation of the Kupffer and endothelial cells of the sinusoids. 
Yamamoto and Kono (1967) also observed multiple formations of
7small nodules in the liver parenchyma with infiltration of 
lymphoid cells in Glisson's sheaths. The spleen in chronic 
cases showed an increase in size and number of lymphoic 
follicles, with a rich infiltration of lymphoic cells around 
the central artery. The visceral lymph nodes had enlarged 
and increased numbers of lymph follicles. There was only a 
slight increase in cellular bone marrow density in chronic 
cases.
C. Characteristics of EIA Virus
1. in ViVo Distribution of EIA Virus.
EIA virus can be isolated from a recovered animal for 
life. Stein et al. (1955) reported a recovered case from which 
he was able to transmit the disease 18 years later through 
blood transfer. During all stages of active EIA, the bone 
marrow, spleen, liver and visceral lymph nodes contain high 
concentrations of the virus. It has also been isolated from 
feces, urine, tears and semen from infected horses.
2. Morphology of EIA virus.
In 1939 Balozet with the aid of filters estimated 
that EIA virus had a particle size of 18 to 50 mu in diameter. 
Using the electron microscope to visualize the virus Reagan 
et al. (1950) described a spherical particle in the sediment 
of serum from an EIA-infected horse to have a size range of 
11 to 49 mu. Ishii et al. (1953) in an electron microscope 
study found a particle with a size of 20 to 50 mu in the serum 
of infected horses.
8Moore (1969), attempted isolation of EIA virus in a 
pure form from horse leukocyte cultures and recovered several 
fractions which adsorbed in the range of 260 - 280 mu. Moore 
was interested in the nature of EIA virus and its nucleic acid 
content. Fraction I, which was infectious, contained DNA. A 
particle in the range of 30 to 50 mu was consistently demon­
strated with the electron microscope. This particle was ex­
tremely sensitive to ether as is EIA virus.
Boyd (1971), in her attempts to isolate and character­
ize EIA virus, was able to demonstrate with an electron micro­
scope two distinct particles sizes. The virons were spherical 
to pleomorphic and measured 45 - 50 mu and 70 - 120 mu in dia­
meter. DNA was found in the purified virions. A horse inocu­
lated with these purified particles developed clinical symptoms 
of EIA.
3. Growth of EIA Virus.
The search for a host other than the equine species 
in which to grow EIA virus has included all of the usual lab­
oratory animals, as well as sheep, goats and pigs; however, 
an alternate host has not been found. Saurino et al. (1957) 
attempted to grow the virus in embryonated chicken eggs.
They were unable to demonstrate the presence of the virus in 
a second passage to embryonated eggs when inoculations were 
made into a susceptible animal.
The use of tissue cultures suggested another method 
to researchers who wished to grow the virus. Kobayashi and 
Kono (1967) reported success in growing the virus in tissue
9cultures of horse leukocytes. EIA virus produced a type of 
cytopathic effect (CPE) in horse leukocytes, but workers 
could not be sure that the effect was actually due to the 
virus as complement fixing (CP) and virus neutralization 
techniques had not yet been proven accurate.
Kono and Kobayashi (1967) attempted to prove that 
the CPE and CF antigen exhibited in horse leukocyte cul­
tures were specific for EIA virus. The presence or absence 
of transmissibility of CPE was checked by individual 
serial passages in horse leukocyte cultures. Clinical cases 
of EIA developed when CPE-positive cultures were inoculated 
into susceptible horses, but no response was noted when 
cultures with no CPE were inoculated. The CPE was concluded 
to be a specific indication for the propagation of the EIA 
virus.
Kono et al. (1970) reported that the CPE could not be 
detected until 48 hours post-inoculation. Viral propagation 
was inhibited by adding 5-iodo-deoxyuridine. This inhibited 
DNA replication in the culture medium, which suggests that 
DNA synthesis is required for viral propagation.
The propagation of EIA virus in primary leukocytes 
provides many advantages over growth in the equine species. 
However, leukocyte cultures can only be maintained for about 
three weeks. Moore et al. (1970) reported improved methods 
of continuous passage of horse leukocyte cultures which gave 
the researcher extended time periods to observe the propaga­
tion of the virus and to demonstrate CPE.
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Kono and Kobayashi (1970) discovered that the serial 
passage of EIA virus in horse leukocyte cultures brought about 
a change in the pathogenesis of the virus. The thirty-first 
passage did not cause clinical symptoms when it was inoculated 
into a susceptible horse; however, an early viremia was exhib­
ited. The EIA disease response was not shown when the 
sixtieth passage was inoculated into a horse.
Various attempts have been made to purify EIA virus. 
Nakajima et al. (1967, 1968) reported growing the virus on 
horse leukocyte cultures. By employing ultracentrifugation, 
DEAE cellulose chromatography, and sucrose density gradient 
centrifugation, the virus was purified. Unfortunately, during 
the purification process, it became innocuous.
4. Hematology
Several research workers (Pehl, 1952; Dreguss and 
Lombard, 1954? Obara and Nakajima, 1961; McGuire et al. ,
1969a) have speculated on the pathogenesis of anemia in EIA. 
They propose that anemia is due to hypoplasia of the bone 
marrow and increased destruction of the red blood cells.
Carbrey (1969) stated that the hyperplasia of the 
bone marrow is attributed to the selective multiplication of 
lymphoid cells and not to increased compensating erythropoietic 
activity. He postulated that the reduced production of red 
blood cells is brought about by the destructive effect of 
population pressures from the proliferating lymphoid cells. 
Carbrey considered the anemia to be similar to leukemia, in 
which the bone marrow is infiltrated with leukemic cells
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causing an aplastic anemia. An Increased hemolysis as Indi­
cated by increased plasma hemoglobin was observed.
Matthias and Schmidt (1956) described inclusion bodies 
in the red blood cells of horses with EIA. These were similar 
to Heinz bodies which are associated with several anemias 
in man. Rothberg et al. (1959) demonstrated that erythrocytes 
containing Heinz bodies have a decreased half-life. McGuire 
et al. (1970) demonstrated that inclusion bodies present in 
the red blood cells of horses with EIA had a maximum range of 
7 to 42 Heinz bodies per 1,000 cells. Normal horses have a 
range of 0 - 4 Heinz bodies per 1,000 red blood cells.
McGuire et al. (1970) indicated that although the 
Heinz bodies were present in larger numbers in horses with 
EIA, they were not significantly involved in the destruction 
of red blood cells.
Kaneko et al. (1969) suggested that enzymatic changes 
in the red blood cell membrane predisposed the cells to Heinz 
body formation, and that these enzymatic changes in the 
membrane of the red blood cells were the cause of hemolysis 
in EIA. McGuire et al. (1969) stated that the hemolysis was 
caused by antigen-antibody reaction on the surface of the red 
blood cells fixing complement with subsequent hemolysis.
Even in the severe anemic conditions brought on by EIA 
reticulocytes and normoblasts were not observed in circulating 
blood, The equine species differ from man and several other 
animals in the absence of reticulocytes and other immature 
red blood cell precursors in the peripheral circulation in
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response to loss or destruction of red blood cells. The mean 
corpuscular volume and mean corpuscular hemoglobin in horses 
with EIA increases slightly. This increase may be due to an 
early release of the larger and younger postreticulocyte red 
blood cells from the bone marrow.
The influx of basophilic round cells (large vacuolated 
mononuclear cells characteristic of horses with EIA) into the 
circulation causes an apparent monocytosis; however, the total 
white blood cell count decreases during the febrile periods 
of horses with EIA.
D. Immunological Response
Stein and Gates (1959) in an early report on the 
immune response, stated that serum from a horse which had 
naturally cleared itself of EIA virus would protect susceptible 
horses when virulent virus was experimentally inoculated. No 
other such report exists in the literature.
Kono (1969) reported a variation in production of CF 
antibody and neutralizing antibody in experimentally EIA- 
infected animals. Most of the horses exhibited some degree 
of CF antibody after the first fever peak, but horses that 
died in the peracute cases did not. Twenty-five horses were 
checked for the presence of neutralizing antibodies. Fourteen 
horses (56 percent) exhibited neutralizing antibody in the serum 
120 days after the first fever spike, while 11 (44 percent) 
never exhibited neutralizing antibody. An explanation was not 
given why neutralizing antibody took 120 days to appear.
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Kono (1968) stated that the CP antigen of EIA virus 
was not a surface antigen but was soluble. Kono's work indi­
cated that this soluble CP antigen was actually an internal 
part of the virus particle.
Ushimi et al. (1969) commented on the ability of EIA- 
infected horses to react to an antigenic stimulus. Sheep red 
blood cells were used as the antigen and were injected into 
horses demonstrating acute and chronic disease. There was a 
tremendous increase in the antibody-producing cells in the 
early acute stage of EIA, with a corresponding increase in 
antibody. When injected into chronic cases of EIA, fewer cells 
were committed to the production of antibody. In the early 
stages of acute EIA, a tremendous proliferation and infiltra­
tion of the spleen and lymph nodes with basophilic round cells 
occurred. This might be the source of the increased production 
of antibody since the fine cellular structure of these cells 
closely resembled that of plasma cells.
E. Diagnosis of EIA
The lack of a valid test for the detection of EIA has 
caused problems in the attempts to control and eradicate the 
disease. Kono and Kobayashi (1966) reported a tissue culture 
antigen that exhibited CF properties but it was abandoned due 
to lack of specificity and inconsistent results. Dreguss and 
Lombard (1954) described the hemagglutination test for diag­
nosis of EIA but it lacked specificity and was discarded.
Moore et al. (1966) described a precipitin test for detection 
of horses with EIA, but the test apparently detected the
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circulation of an abnormal protein and not a specific EIA 
antibody. Saurino et al. (1966) described an immunoadherence 
test and a hemagglutination inhibition test, but they were 
not adopted because antibody could not be detected in the 
serum.
The most promising test today is the immunodiffusion 
test proposed by Coggins and Norcross (1970) in which a crude 
extract of the spleen from infected horses is utilized as the 
antigen. The test detects the presence of a circulating 
antibody in the serum of EIA-infected horses as early as 18 
days post-inoculation. This antibody is believed to be 
specific for EIA virus. While the immunodiffusion shows 
promise, the only method currently accepted is animal inocu­
lation and the appearance of clinical symptons of EIA.
F. Other Anemias
Anemias develop only when the rate of destruction of 
red blood cells exceeds the capacity of the bone marrow to 
produce erythrocytes. There are several other types of 
anemias whose pathological changes closely resemble those in 
the EIA disease syndrome. Other closely related anemias must 
be reviewed in order to eliminate the possibility that the 
pathological changes develop in the same target tissue as 
those of EIA.
1. Artificially-Induced
There are two major hypotheses about drug-induced 
immune hemolytic anemias. The first hypothesis is that the
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drug forms a complex with a soluble blood macromolecule that 
acts as an antigen and which invokes an immune response by 
production of antibody. If the animal is reexposed to the 
drug, the antigen-antibody complex passively adsorbs to the 
surface of the red blood cell. The second hypothesis specu­
lates that the red blood cell acts as a carrier protein for 
the drug antigen thus invoking an immune response. Reexpo­
sure produces identical results as in the first hypothesis 
(Shulman, 1964).
Cortisone-induced anemia and hyperlipemia are actually 
dilution anemias which result from increased lipids in the 
blood. There appears to be no relation to the hemolytic 
anemias brought on by cholesterol feeding and there is no 
change in the concentration of cholesterol or phospholipid 
in the red blood cells (Moran et al.,1966).
A number of drug-induced hemolytic anemias are 
associated with impairment of red blood cell metabolism. The 
incubation of red blood cells deficient in glucose-6-phosphate 
dehydrogenase (G-6-PD) with oxidizing drugs such as acetyl- 
pheny1-hydrazine causes loss of glutathione and formation of j 
Heinz bodies. Denatured hemoglobin, resulting from hydrogen 
peroxide produced in the cell, attaches to the cell membrane, 
causing early destruction of the cell by the reticulo-endothe- 
lial system. Normal G-6-PD cells have the ability to produce 
sufficient TPNH to reduce the glutathione after exposure to 
hydrogen peroxide and thus prevent damage to the hemoglobin 
(Zalusky, 1970 and Jaffe, 1970b).
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2. Hereditary Predisposition to Anemias.
Fourteen types of hereditary anemia caused by enzyme 
deficiencies were reviewed by Jaffe (1970a). Six of these 
enzyme deficiencies have not been well defined, with all cases 
relating to glycolytic enzymes. Mills et al. (1968) reported 
that red blood cells with low levels of ATP lost their 
biconcave shape and were predisposed to hemolysis by the 
reticulo-endothelial system. The low levels of ATP were 
believed to result from over-utilization of adenine nucleotide, 
which could have been causes by excess requirements of ATP 
for active transport across an altered cell membrane, excessive 
requirements for biosynthetic processes and/or loss due to 
excessive phosphatase activity inside the cell.
Unstable hemoglobin such as hemoglobin H, an inherited 
alteration in the Beta chain of the hemoglobin tetramer, will 
undergo hemolysis when exposed to sulfonamides both in vivo 
and in vitro ( Rigas and Koler, 1961).
3. Lipid-Involved Hemolytic Anemias That Resemble EIA.
Okey and Greaves (1939) fed guinea pigs (GP) high
levels of cholesterol. After five weeks on this diet, the 
GP became severely anemic and the liver developed enormous 
fatty infiltrations. These workers postulated that the liver 
lost its ability to esterify and hold back the extra choles­
terol which exerted a surface tension effect on the red blood 
cell membrane resulting in hemolysis. Silver et al. (1964) 
fed rabbits high cholesterol diets which caused hyperlipemia, 
liver damage, enlarged spleens and severe anemia. Splenec-
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tomies relieved the anemia only temporarily because the spleen 
is the major reticulo-endothelial organ for removal of damaged 
red blood cells. Silver et al. stated that the severity of the 
hemolytic anemia could be corrolated directly to the liver 
damage.
Westerman et al. (1970) reported on a biphasic anemia 
produced by cholesterol feeding. The first phase is a dilu- 
tional anemia caused by increased lipids in the blood. The 
second phase occurs when the ratio of plasma to red blood 
cell cholesterol is increased. As the red blood cholesterol 
increased the life span of the red blood cell decreased.
The alteration in this relationship may be associated with 
decreased affinity of serum lipoprotein for free cholesterol. 
Hemolytic anemia is due to transfer of free cholesterol to the 
red blood cell or to the severity of associated liver damage.
It is not due to free or esterified cholesterol in the serum.
Patients with Zieve's syndrome, i.e., hyperlipemia, 
which is caused by alcoholism and liver damage, exhibit 
hemolytic anemias. Westerman et al. (1968) postulated that 
these hemolytic anemias were caused by lipids coating the 
red blood cell and altering the cell membrane, thus shortening 
the life span.
Blass and Dean (1966) suggested that hyperlipemia and 
hemolytic anemia are independent of each other, Lysolecithin, 
a strong hemolytic agent, when more than doubled in concentra­
tion in vivo did not cause hemolysis. Hemolysis was believed 
to be due to liver damage, but they did not speculate on the 
mode of action.
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Neerhout (1968) reported that patients with liver
disease showed increased total lipid, lipid phosphorus and
cholesterol. The most striking change in the erythrocyte
stromal lipids was in the phospholipid fraction. Phosphatidyl
«
choline increased two-fold, palmitic and oleic acids increased, 
but stearic and arachidonic acids decreased in concentration.
The concentration of linoleic acid was variable. The red 
blood cell stromal lipid alterations could be attributed to 
increases in cholesterol and phosphatidyl choline. Neerhout 
believed that the red blood cell changes were associated with 
hepatic disease and should not be considered to be produced 
by nonspecific plasma hyperlipemia. Neerhout"s hypothesis could 
be supported by the hyperlipemia caused by fasting (Zawilaki 
and Paluszak, 1970) and by stress in which hemolytic anemia 
was not present (Taggart and Carruthers, 1971).
Horses infected with EIA exhibited an increasingly 
altered lipoproteinemia as the disease syndrome became more 
pronounced. Horses usually had a grossly lipemic serum 
prior to death (Gainer et al., 1966a). Gainer et al. employed 
paper electrophoresis to measure the percentages of alpha 
lipoprotein (PAL) and beta lipoprotein (BL). The normal values 
for PAL were established at 56.9 percent. The animals were 
then experimentally infected with equine serum containing 
virulent EIA virus.
The PAL increased for 3 to 5 days post-inoculation, 
while the BL decreased. During the next 27 days the PAL
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declined to a level of only 2 percent while the BL Increased at 
least ten-fold. These workers pointed out that in a case of 
toxic hepatitis in a horse, the PAL dropped to zero (0) while 
the BL showed a great increase. When horses with equine 
piroplasmosis were tested for alterations in the PAL, the 
values were found to be in the normal range.
Gainer et al. made two principle observations: 1.
As the temperature became elevated (biphasic temperature 
response), the lipoprotein values changed quite rapidly in 
a triphasic response. 2. The experimentally-infected animals 
did not experience a large decrease in packed red blood cell 
volume.
In a natural case of EIA, a decreased packed red blood 
cell volume that followed the altered PAL Values was observed. 
The cause of the altered PAL were unknown but Gainer proposed 
several possibilities, including histopathological liver damage, 
direct extrusion from the fat deposits of the body, destruction 
of erythrocytes with lipid release and low levels of lipoprotein 
lipase in EIA-infected horses.
Gainer et al. suggested that the target tissue for the 
EIA virus was the hepatic cord cells. The liver function was 
then altered to such an extent that it could no longer proper­
ly metabolize serum lipids, which resulted in an increased BL.
The normal horse has a serum lactic dehydrogenase (LDH) 
range of 200 to 830 Berger-Broida units (BBU) with a mean 
value of 572 BBU. Gainer et al. (1966b) found elevations up 
to 19,600 BBU in the serum of a horse terminal with EIA.
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Alterations of LDH and PAL coincided quite closely, and may 
have stemed from altered liver function. Gainer et al. 
believed that the elevated LDH was probably a direct result 
of LDH released from the lysed red blood cells.
I
MATERIALS AND METHODS
A. Experimental Animals
Horses of the Shetland and mixed Quarter breeds were 
purchased from a rancher in West Texas. The incidence of 
natural insect vectors is low in this area because of the 
low humidity and as a result the incidence of EIA in the 
equine population of that area is reduced. All of the horses 
purchased from that area of Texas have also been negative for 
EIA.
The animals were grouped into lots of six and 
underwent a round robin. The round robin consisted of trans­
fusing each horse with 300 ml of whole blood obtained from 
another animal in the group. The horses were then observed 
for 90 days for clinical signs of EIA. These observations 
included taking rectal temperature twice daily throughout 
this period. The group of horses was considered free of the 
virus only after one of the 6 animals was injected with 300 ml 
of whole blood from a known carrier and clinical EIA developed 
in this animal. The remaining 5 negative animals in each of 
the group were subsequently employed in the infectivity trials.
All animals were fed a ration of Purina Horse Checkers 
supplemented with 1000 units of Vitamin D per lb of feed.
The horses were fed at a rate of 1 1/4 lb of feed per 100 lb 
of body weight. Water was available ad libitum.
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Experimental EIA was produced by inoculating the 
susceptible animals with 100 ml of whole blood via the jugular 
vein from a carrier. The horses were housed in individual 
screened stalls to eliminate the possibility of insect vectors 
spreading EIA to susceptible animals in the surrounding area.
B. Collection and Preparation of Blood
Blood samples were collected at three-day intervals 
via jugular venipuncture into 50 ml evacuated containers which 
contained 50 mg disodium ethylenediamine tetraacetic acid 
as an anticoagulant.
The blood samples were centrifuged at 2000 x g for 
20 minutes at 4° C. Plasma was removed and stored in 50 ml 
glass vials after being passed under a stream of nitrogen.
The erythrocytes were washed three times with physiological 
saline and the white blood cells were removed by aspiration.
The pellet of erythrocytes that remained after the last washing 
was passed under a nitrogen stream and stored in a 50 ml glass 
vial. The plasma and erythrocyte samples were stored at -20° C 
until lipid extraction was initiated.
C. Lipid Extraction
All solvents used in this experiment were redistilled, 
with the exception of diethyl ether. Erythrocytes and plasma 
were extracted with 20 volumes of chloroform-methanol (2/1, v/v). 
In order to prevent clumping, erythrocytes were added slowly 
to cold methanol while being stirred with a magnetic stirrer.
The mixture of erythrocytes and methanol was stirred
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vigorously for about 5 minutes before chloroform was 
slowly added. The extracted mixtures of erythrocytes 
and plasma were filtered through 2 thicknesses of diethyl 
ether-extracted Whatman No. 1 filter paper. This filtrate 
was placed in a round-bottomed flask and concentrated at 
65° C to about 30 ml on a rotary-vacuum evaporator (Wallace,
1966; Ways and Hanahan, 1964).
Approximately 5 grams of NaCl were placed in a separa­
tory funnel which was wetted with chloroform to test for possible 
leaks. The sample of extracted lipid mixture was added to the 
separatory funnel and distilled water added to about 3/4 the 
volume of the funnel. This mixture was vigorously shaken and 
allowed to stand for 15 minutes to allow separation of the 
phases (Folch, 1957). The lower fraction (lipid-chloroform 
mixture) was drawn off into a flask containing anhydrous 
sodi&ri'sulfate. Three additional extractions were carried 
out on the material in the separatory funnel with 5 ml chloro­
form added prior to vigorous shaking.
The flask containing the lipid-chloroform mixture and 
anhydrous sodium sulfate was flushed with nitrogen and allowed
to dry for 1 1/2 hours at 4° C.
D. Preparation of Methyl Esters
After drying, the lipid-chloroform mixture was placed 
in a 20 x 150 mm tube and evaporated to dryness under a stream 
of nitrogen in a water-bath at 70° C. Five ml of a transmethyla­
tion solution composed of 150 ml of dry methanol, 75 ml benzene 
and 7.5 ml concentrated sulfuric acid were added to each tube
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(Wallace et al., 1965). The mixture was refluxed at approxi­
mately 120° C for 1 1/2 to 2 hours. Five ml of petroleum 
ether and 15 ml distilled water were added to each tube 
(Stoffel et al., 1959; Connellan, 1965). The tubes were 
vigorously shaken and allowed to stand until the petroleum 
ether and water phases had separated. The lower water phase 
was removed with a Pasteur pipette and the washing procedure 
repeated 3 times to remove all traces of acid. After the 
final wash the petroleum ether layer was removed and dried 
over anhydrous sodium sulfate under nitrogen for at least 
1 1/2 hours. The methyl esters were subsequently concentrated 
by evaporation under nitrogen in a water-bath at about 65° C 
and drawn into a microliter syringe and injected into a gas 
chromatograph.
E. Gas-Liquid Chromatography of Acids
The gas-liquid chromatography phase of the study was 
carried out with a F & M Model 700 gas chromatograph. It was 
equipped with dual columns and dual flame ionization detectors. 
The columns were 10 feet in length x 1/4" (O.D.) and were 
packed with 8% polyethylene glycol adipate (EGA) on acid-washed 
Chromport (80-100 mesh). The columns were hand-packed by 
vibration and conditioned in the F & M Model 700 overnight at 
195° C with a helium flow. The following morning the flow 
rate for the carrier gas (helium) was established at 60 ml per 
minute for each column. The flame ionization detectors were
supplied with a hydrogen and compressed air mixture. The 
hydrogen flow rate set at 18 pounds per square inch and 
the compressed air at 15 pounds per square inch. The injec­
tion port and detectors of the Model 700 were maintained at 
275° C while the columns were held at 180 0 C (James, 1960).
P. Thin-Layer Chromatography to Separate Lipid Classes 
Pyrex plates (200 x 200 mm) were washed, rinsed, 
oven-dried, and cleansed with methanol before use. A soupy 
suspension of Silica Gel G, prepared by mixing 22.5 gm with 
50 ml of water, was spread over the glass plates with a 
Brinkmann adjustable applicator. The plates were gently 
shaken to thin thickened areas and allowed to dry for 
30 minutes. They were then placed in an oven for 30 minutes 
at 115 ° C for activation prior to being used for lipid 
separation. The activated plates were removed from the oven 
and allowed to cool to ambient temperature. A lane of about 
20 mm in width was marked on one side of the plate (Mangold, 
1961). A standard mixture (Hormel Institute Standard Mixture 
II A) containing cholesterol, cholesterol oleate, triolein, 
oleic acid and hydrogenated lecithin was spotted about 15 mm 
from the bottom of the plate in the control lane. The lipid 
extract was concentrated in a water-bath to about 2 ml. This 
was drawn into a glass tuberculin syringe and spotted along a 
line 15 mm from the bottom of the plate. In order to regulate 
the size of the spots, a bent 22 gauge needle was employed.
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The solvent system used to develop the TLC plates 
was composed of 126 ml petroleum ether, 22.5 ml diethyl 
ether, and 1.5 ml formic acid (Mangold, 1961). The solvent 
was poured into a Desaga chromatography tank. The paper wick 
along the back wall of the tank was soaked with solvent to 
insure a saturated atmosphere. The TLC plates were carefully 
placed in the tanks and developed until the solvent front was 
approximately 10 mm from the top of the plate. After develop­
ment, the plate was placed under a stream of nitrogen to 
remove the solvents.
The lipid classes were visualized by spraying the TLC 
plate with 2'7' dichlorofluoresein and observing under long 
wave ultra-violet light. Bands corresponding to standard 
lipids were marked (Stahl, 1965). The bands were scraped from 
the TLC plate onto sheets of glassine weighing paper and then 
transferred to 20 x 150 mm tubes to which 5 ml of transmethyla­
tion mixture had been added. The material was processed in the 
same manner as that employed in esterifying the total lipid 
extract.
G. Method for Determining Fatty Acids
The method employed to determine the retention time 
of unknown fatty acid esters involved the passage of a 
standard ester through the gas chromatograph and comparison 
of the known retention times with the retention times of the 
unknown esters. The standard mixture contained the following 
fatty esters: C11:0, C12:0, C13:0, C14:0, C15:0, C16:0,
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C17:0, C18:0, C18:l, C18:2, C20:0, C22:0, C22:l, C24:0, 
and C24:l. In order to determine the concentrations of the 
fatty acids the triangulation method was employed. The 
height and 1/2 of the width of the peak were employed to 
calculate peak area. The total area of all peaks was cal­
culated and the relative percentage area of each peak was 
determined (James, 1960).
RESULTS AND DISCUSSION 
The primary purposes of this investigation were:
(1) to study the changes in the fatty acids of the total 
lipids and the fatty acids of lipid classes in the plasma 
and erythrocytes of horses infected with EIA and (2) to 
determine if the lipemia and consequently the lipids or 
fatty acids present in the blood could be responsible for 
the hemolytic anemia. It has been established that various 
lipids can produce hemolysis in vivo (Blass and Dean, 1966).
Due to the lack of information in the literature 
relating to this investigation, an initial study was required 
to determine the ranges of total fatty acid values of normal 
horse blood. Once this was accomplished, it was possible 
to study the alterations which occurred in the blood lipids 
of EIA-infected horses.
A. Establishment of Pre-Inoculation Values
The initial investigation provided data on the ranges 
in relative concentrations of fatty acids in the total lipids 
of plasma and erythrocytes of horses before inoculation with 
EIA virus.
The major fatty acids in the plasma lipids of horses 
before infection were C16:0, C16:l, C18:0, C18:l, C18:2 and
28
29
C18:3, Figures 1 and 2 represent data on body temperature 
and relative percent composition of fatty acids present in 
the total lipids of plasma obtained from Horse No. 3 for 
19 days before inoculation with EIA virus. During this 19-day 
period, C16:0 and C18:0 had a concentration range of 13 to 17 
percent. C16:l and C18:3 had a range of 1.5 to 4.5 percent 
concentration. C18:2 showed the highest concentration of any 
fatty acid in the total lipids of plasma in the horse prior 
to infection. It ranged between 34.87 and 43.39 percent. 
Investigations to determine the concentrations of fatty acids 
in plasma were extended to 48 days before inoculation in other 
animals, and similar results were obtained as shown in Tables 
1 and 3. These data are felt to be representative of the 
fatty acids in plasma of normal horses on the feed ration 
outlined in Materials and Methods, Section I.
The second part of the initial investigation involved 
determining the ranges in concentrations of fatty acids in 
the total lipids of erythrocytes of horses prior to inocula­
tion. Figures 3 and 4 represent the data collected for a 
period of 19 days before infection. The major fatty acids 
in the erythrocytic lipids of Horse No. 3 were C16:0, C16:l, 
C18:0, C18:l, C18:2 and C24:0.
The major fatty acid in the erythrocytes was C16:0 
which comprised about 25 percent of the total lipid extract 
(Table 2). C18:0 and C18:l made up approximately 31-38
percent and C18:2 and C16:l about 3 percent of the total 
lipids in the erythrocyte as shown in Table 2. There was
Figure 1. Plots of body temperature and percent of C18:l and C18:2 of the fatty acids 
in the total lipid extract of plasma from Horse No. 3.
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Table 1. Percent of individual fatty acids of the total lipid extract from plasma of Horse No. 3
Fatty
Acid
Davs Before Inoculation Davs After Inoculation
19 11 7 3 0 3 7 10 14 17 21 24 28 31
C14:0 0.72 0.99 0.87 0.90 1.00 0.81 0.92 0.52 Tr® 1.20 1.15 1.19 1.24 1.33
C16:0 13.91 14.42 14.90 14.63 14.99 17.02 13.98 12.81 19.20 17.68 23.30 21.67 21.93 19.41 '
C16:1 1.94 2.45 2.92 2.76 2.73 2.37 3.06 2.46 3.27 5.23 4.66 5.05 5.29 5.24
C18:0 16.33 14.71 14.90 15.62 15.75 17.78 17.57 18.62 13.66 14.43 13.22 11.55 10.18 14.40
C18:1 15.44 24.87 17.41 15.55 16.75 14.18 16.24 12.81 18.45 22.79 23.13 23.39 26.06 25.81
C18:2 43.39 34.87 40.29 41.72 40.36 42.27 39.51 45.17 34.86 27.63 25.72 27.18 23.77 25.75
C18:3 3.52 2.91 2.82 3.12 3.13 0.49 3.17 1.89 4.17 6.54 5.08 4.69 5.77 5.12
C20:0 0.41 0.41 0.50 0.34 0.34 0.38 0.51 0.49 0.24 0.49 0.15 0.19 0.24 0.16
C20:1 0.40 0.89 0.59 0.36 0.37 0.56 0.47 0.44 0.33 0.41 0.47 0.37 0.45 0.35
C21:l - 0.23 - - - - - - - - - m -
C20:4 0.59 0.55 0.90 0.59 0.85 0.53 0.53 0.60 1.19 0.45 0.58 1.83 1.98 0.51
C22:0 0.29 0.41 0.59 1.08 0.21 0.32 0.59 0.31 0.28 0.18 0.19 0.22 0.17 0.10
C22:1 Tr Tr Tr Tr Tr 0.11 Tr Tr 2.51 0.37 Tr Tr Tr Tr
C24:0 0.30 Tr Tr 0.34 0.08 0.38 0.23 0.49 0.14 0.50 0.53 Tr Tr Tr
C24:1 • • - • • - • — • • - - -
s/ub 0.48 0.46 0.49 0.51 0.50 0.61 0.54 0.52 0.52 0.54 0.65 0.56 0.53 0.56
^race amount.
^Saturated to unsaturated fatty acid ratio.
Table 2. Percent of individual fatty acids of the total lipid extract from erythrocytes of Horse No. 3.
Fatty Davs Before Inoculation________________________ Davs After Inoculation
Acid 19 11 8 0 2 6 9 13 16 20 23 27 30
C14:0 0.70 0.47 0.43 0.69 0.71 0.50 0.42 0.31 0.63 0.42 0.39 0.90 0.74
C16:0 24.40 20.90 20.75 21.40 23.57 19.45 21.57 5.60 23.30 16.77 17.16 19.82 21.47
C16:1 2.84 1.94 1.58 1.80 3.13 1.55 1.60 0.91 2.53 1.50 1.89 1.62 1.69
C18:0 21.32 19.32 19.71 19.86 21.00 17.21 16.73 3.95 24.57 19.98 17.63 18.80 22.30
C18:1 14.84 12.10 18.57 18.39 21.54 16.98 14.74 4.37 19.29 15.04 15.04 14.31 15.62
C18:2 1.65 1.94 2.66 1.64 3.18 1.79 1.26 3.49 1.65 1.40 2.12 3.43 1.56
C18:3 Tra Tr Tr Tr Tr Tr Tr Tr 0.25 Tr Tr Tr Tr
C20:0 1.40 6.46 1.71 0.59 0.56 0.45 0.53 Tr 0.25 0.28 0.70 0.22 0.20
C20:1 1.77 2.12 1.08 0.95 1.00 0.88 1.14 3.41 1.09 0.90 0.73 0.16 1.10
C21:0 0.98 1.47 2.03 1.07 1.08 1.22 0.92 1.06 0.67 0.71 1.19 0.38 0.67
C21:1 1.83 4.68 4.15 3.98 3.96 3.40 3.58 1.42 4.26 3.25 2.27 3.00 3.32
C20:4 1.46 2.18 0.80 1.54 0.64 0.50 0.74 4.22 0.84 0.42 0.45 1.31 0.54
C22:0 1.83 1.94 1.29 1.37 1.98 1.54 2.08 9.86 1.90 1.53 1.21 3.27 2.07
C24:0 5.49 4.71 4.27 6.11 5.87 4.79 5.40 3.27 7.25 5.34 5.10 3.77 3.98
C24-.1 1.08 9.67 5.23 5.36 8.33 10.14 6.36 7.34 7.64 7.16 12.19 4.69 6.43
C24:U1 13.27 7.06 12.63 7.55 Tr 7.67 10.58 38.03 1.06 2.54 4.17 4.35 6.66
C24:U2 - - - - - - - - 0.00 6.35 14.45 15.28 3.11
s/ob 1.44 1.32 1.07 1.23 1.31 1.05 1.19 0.38 1.51 1.16 0.81 0.97 1.28
a
Trace amount.
^Saturated to unsaturated fatty acid ratio.
Table 3. Percent of individual fatty acids of the total lipid extract from erythrocytes of Horse No. 9.
Fatty
Acid
Davs Before Inoculation Davs After Inoculation
48 46 43 7 4 0 3 7 10 14 17 20
C14:0 3.67 0.74 1.27 2.15 0.74 0.68 2.46 1.29 1.10 1.22 1.65 0.82
C16:0 15.35 16.50 16.99 21.19 25.54 24.71 20.60 20.94 14.30 13.25 26.68 25.42
C16:l 4.34 1.65 1.36 2.58 1.69 1.51 7.09 2.36 4.70 1.74 2.48 1.58
C18:0 14.99 16.50 14.87 17.67 19.35 19.91 13.87 17.04 14.10 22.60 22.59 36.77
C18:1 15.04 16.31 13.25 15.20 17.56 17.20 15.59 14.24 23.20 25.50 23.37 21.11
C18:2 3.30 2.44 0.93 3.83 1.13 1.80 1.46 1.68 0.70 0.54 2.20 1.01
C18:3 2.27 1.36 1.85 1.75 1.33 1.49 0.92 1.22 8.00 5.70 0.55 0.19
C20:0 1.85 1.11 0.64 2.68 2.06 1.98 1.51 2.06 7.20 1.37 9.30 1.20
C20:1 3.56 2.27 1.44 3.35 0.90 1.00 1.05 0.42 1.10 5.19 0.49 0.31
C21:0 3.92 2.19 2.21 1.15 2.35 3.22 1.87 1.74 1.40 1.74 1.60 0.50
C20:4 1.55 1.03 1.15 3.81 1.38 1.65 0.46 0.35 1.80 3.62 - 0.63
C22:0 9.66 15.55 12.70 8.92 - - 0.74 0.72 3.10 1.11 - 2.21
C24:0 1.70 1.69 1.43 1.89 5.61 5.26 2.74 2.87 0.70 2.96 3.97 3.93
C24:1 8.73 17.54 17.56 - 11.94 13.21 6.98 6.65 1.20 - - -
S/Ua 1.32 1.27 1.37 1.76 1.55 1.47 1.31 1.73 1.01 1.05 2.26 2.85
aSaturated to unsaturated fatty acid ratio.
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evidence that the erythrocytes contained longer chain fatty 
acids than the plasma as seen in Table 2 and that the erythro­
cytes contained about 5 percent of C24:0. Table 3 gives 
supporting data which represent a 48-day testing period prior 
to infection of Horse No. 9 with EIA virus.
B. Changes in Fatty Acids of Total Lipid Extract in Experi­
mental EIA
The horses were injected with 100 ml of whole citrated 
blood from a known EIA carrier. One day after inoculation 
the body temperature of Horse No. 3 became elevated and did 
not return to the normal range. It died after 30 days.
Figures 1 and 2 show the changes that occurred in the plasma 
during the course of experimental EIA of Horse No. 3. The 
largest changes were found in C18:l and C18:2. C18:2 had an
almost equal and opposite change to C18:l (Figure 2). Nine 
days after inoculation Horse No. 3 had a temperature of almost 
105°F, the highest recorded, and C18:2 reached its maximum 
concentration of 45.17 percent in the plasma. C18:2 dropped 
from 45.17 percent on day nine to 25.72 percent on day 20 
after inoculation. Twenty days after inoculation the concen­
tration of C18:2 dropped for the first time to a lower percen­
tage than C18:l. C16:0 became elevated to 23.3 percent at
this time and remained elevated until death. As the concen­
tration of C18:0 increased the concentration of C16:0 dropped 
but to a lesser degree as shown in Figure 2. C16:l and C18:3
became elevated to about twice their initial concentrations 
by day 16.
36
Other fatty acids present in the plasma included 
C14:0 , C20j 0, C20:l, C21:0f C21:l, C22:0, C22:l, C24:0 and 
C24:l. Since their values were usually less than 1 percent 
and no marked changes were noted, they were not considered 
significant. The data are listed in Table 1.
The fatty acid alterations in the erythrocytes were 
more drastic than the changes in the plasma. Figures 3 and 
4 show that almost all of the major fatty acids increased 
slightly with the exception of C24:0 which dropped from about 
10 percent to zero percent in 2 days. Between days 2 and 9 
after inoculation there was a small decrease in the concen­
trations of C16:0, C18:0, and C18:l. From day 9 to day 13, 
all three components decreased to about one-fourth of their 
preinoculation levels. The drastic decrease in these three 
fatty acids of the erythrocyte was offset by an increase in 
C24 fatty acids of unknown saturation and/or branching (C24:U1) 
as shown in Figure 4. Two days after inoculation C24:U1 
disappeared but by day 13 it increased to 38.03 percent of the 
total erythrocytic lipids in Horse No. 3. By day 16 C24:U1 
dropped to less than 30 percent and remained there until the 
horse died. C24 fatty acids of unknown saturation and branch­
ing (C24:U2) became elevated to about 15 percent but decreased 
to less than 5 percent before death.
Figure 5 represents the alterations in the ratio of 
saturated to unsaturated fatty acids during the course of 
experimental EIA. The ratio of saturated to unsaturated fatty
Figure 3. Percent of C16:0, 018:0, 018:1, and 018:2 of the fatty acids in the total 
lipid extract of erythrocytes from Horse No. 3.
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Figure 4. Plots of body temperature and percent of C16:l, C24:U1, and C24:U2 of the 
fatty acids in the total lipid extract of erythrocytes from Horse No. 3.
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Figure 5. Ratio of saturated to unsaturated fatty acids of the total lipid extract 
of the plasma and erythrocytes from Horse No. 3.
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acids was relatively constant in the plasma throughout the 
course of the disease. The erythrocytes of Horse No. 3 
shifted markedly from day 9 to day 13 after inoculation and 
was due to the decrease in the concentrations of C16:0 and 
C18:0 and the large increase in the C24:U1. The saturated 
fatty acids had greatly increased over the unsaturated fatty 
acids by day 16 after inoculation. The saturated acids 
later decreased below preinoculation values and at death 
returned to the initial range. Horse No. 11 survived an 
experimental infection of EIA, and did not exhibit an increase 
in the unsaturated fatty acid concentration as shown by Horse 
No. 3 which died from acute EIA.
Horse No. 11 survived the experimental infection and 
exhibited clinical symptoms of EIA. Body temperature peaked 
at 104.5°F 9 days after infection until day 20 at which time 
it returned to a normal range. It remained normal until the 
experiment was terminated 62 days after infection (Figure 6, 
Table 4).
The fatty acids of the total lipid-extract of the 
plasma of Horse No. 11 had patterns almost identical with 
the animals that died from the disease. C18:2 increased 
slightly for 9 days after infection and then declined to a 
range less than half of its initial value 18 days after infec­
tion. C18:2 returned to a normal range on day 22 and remained 
at this area until the experiment was terminated at 62 days. 
The concentration of C18:l (Figure 6 and Table 4) exhibited
an almost equal and opposite change as seen for C18:2 
throughout the course of the experiment.
Figure 6. Plots of body temperature and percent of C18:l and C18:2 of the fatty acids 
in the total lipid extract of plasma from Horse No. 11.
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Table 4. Percent of individual fatty acids of the total lipid extract from plasma of Horse No. 11
Davs C14:0 C16:0 C16:1 C18:0 C18:1 C18:2 C18:3 C20:0 C20:1 C21:0 C20:4 C22:0 C22:1 C24:0 s/ua
a
o _ « 19 0.43 13.56 1.39 20.68 12.22 45.83 1.03 0.45 0.26 0.24 0.71 0.15 0.20 0.76 0.59•H
4Jal 16 0.53 13.29 1.47 19.60 13.29 44.32 1.01 0.41 0.30 0.30 0.79 0.15 0.61 1.75 0i58CD.-i 12 0.59 13.93 1.50 18.78 14.59 42.77 1.26 0.42 0.30 0.23 0.92 0.23 0.41 1.96 0.593O
2
8 0.55 13.77 1.46 19.14 13.94 43.49 0.88 0.45 0.38 0.24 0.97 0.21 0.21 2.25 0.60
QH
0 0.58 13.10 1.70 19.60 15.31 43.53 1.03 0.50 0.57 0.35 0.98 0.11 Tr 0.39 0.55
2 0.58 12.93 1.44 19.69 14.13 42.24 1.81 0.42 0.35 0.29 1.03 0.93 0.67 1.77 0.59
6 0.77 13.50 2.88 13.82 12.54 48.82 2.05 1.28 0.38 0.19 0.51 Tr Tr Tr 0.44
9 0.63 13.74 2.06 17.77 11.02 48.67 1.22 0.36 0.21 0.17 1.03 0.32 0.13 Tr 0.51
a 13 1.35 12.85 7.89 10.60 27.62 24.41 8.78 0.10 0.31 0.30 0.78 0.10 0.48 1.23 0.38
o
•H 16 2.02 18.88 7.66 8.83 27.89 20.83 9.19 0.05 0.24 0.18 0.36 0.07 0.47 0.58 0.46■U
<d 20 0.56 15.58 2.58 17.49 11.77 43.05 1.01 0.34 0.45 0.67 2.24 Tr Tr Tr 0.57
3 23 0.52 12.75 4.56 18.07 15.36 41.07 2.12 0.33 0.30 0.25 1.00 0.23 0.14 0.70 0.51O
o 27 0.58 13.30 2.22 17.61 15.79 42.29 1.80 0.38 0.45 0.38 0.99 0.37 0.34 0.64 0.52c
M 30 0.71 11.52 2.52 18.59 17.31 40.26 2.17 0.41 0.54 0.38 1.28 0.23 0.15 1.03 0.51
Vi 34 0.62 13.97 2.36 16.60 16.66 40.79 1.84 0.35 0.41 0.31 1.09 0.81 0.24 1.40 0.54V
•u 37 0.55 12.79 2.04 15.49 13.12 45.26 1.60' 0.33 0.29 0.44 1.06 2.00 0.87 1.64 0.52m
C 40 0.67 13.67 2.40 18.19 14.98 41.52 1.54 0.33 0.46 0.34 1.21 0.35 0.31 1.94 0.57
to 43 0.50 13.74 2.17 18.53 13.34 42.38 1.80 0.31 0.36 0.29 1.30 0.43 1.18 1.30 0.56
a) 48 0.51 13.29 2.21 19.41 13.72 44.02 1.41 0.29 0.27 0.26 1.23 0.57 0.18 0.56 0.55fl
51 0.50 13.30 1.85 18.30 14.25 43.84 1.63 0.38 0.33 0.32 1.36 0.35 0.31 0.83 0.53
55 0.59 13.16 2.32 18.59 14.4 42.52 1.64 0.37 0.37 0.25 1.49 0.54 0.84 0.59 0.54 -
58 0.59 13.93 2.36 18.43 14.86 41.81 1.56 0.41 0.36 0.31 1.13 0.48 0.31 1.24 0.57
62 0.70 14.02 2.88 17.40 16.18 39.78 2.42 0.31 0.35 0.29 1.34 0.50 0.48 1.06 0.54
Saturated to unsaturated fatty acids. 
^Trace amount.
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Concentrations of C16:0 and C18:0 from Horse No. 11 
were similar to those of Horse No. 3 with one notable excep­
tion. C16:0, which remained elevated in the plasma of the 
horses which died of EIA returned to normal in Horse No. 11 
by day 22. The greatest changes which occurred in the plasma 
of the surviving horse which recovered were C16:l and C18:3. 
These two fatty acids increased three-fold by 13 days after 
infection and remained elevated for 4 days, at which time 
they began to decline and reached a normal range on day 20 
as shown in Table 4.
The changes in fatty acids of erythrocytes of Horse 
No. 11 exhibited similar alterations in C18:0, C18:l, and 
C18:2 as did Horse No. 3. There was one notable difference 
in the fatty acids of erythrocytic lipids of horses that died 
as a result of the disease and those which survived. Horse 
No. 3 in the acute stage of EIA had about a three-fold decrease 
in the concentration of C16:0. Horse No. 11 had a relatively 
constant concentration of C16:0 throughout the course of the 
disease (Table 5).
C. Fatty Acids of Lipid Classes of Plasma
Thin-layer chromatography was employed to separate 
the lipid classes in order to obtain data on the fatty acids 
of the individual classes of lipids by GLC. The TLC method 
separated the lipids into five classes: PL, sterols, FFA,
TG, and SE. All classes of lipids were analyzed for fatty 
acid composition except the sterol fraction.
Table 5. Percent of individual fatty acids of the total lipid extract from erythrocytes of Horse No. 11.
Fatty
Acid
Davs After Inoculation
0 3 7 11 19 21 25 28 32 34
C14:0 1.26 0.76 0.74 0.74 0.65 0.27 0.66 0.46 1.97 0.47
C16:0 20.96 23.00 24.72 23.88 26.62 17.89 22.45 15.94 26.40 12.12
C16:l 1.98 2.16 6.00 1.88 1.31 1.47 2.08 1.79 6.93 1.80
C18:0 19.54 20.76 23.08 13.22 24.18 14.03 21.86 15.93 20.67 10.60
C18:1 18.44 21.11 8.34 11.58 20.46 11.51 21.16 13.73 23.17 7.72
C18:2 13.87 2.55 2.47 2.76 1.91 1.45 2.11 1.81 11.61 7.67
C18:3 0.09 0.07 0.87 0.07 - 1.10 - - 0.63 0.27
C20.-0 0.88 0.93 0.72 0.61 0.67 - 0.92 0.48 0.19 1.50
C20:l 1.48 1.62 1.43 1.04 1.31 0.78 1.06 0.99 0.12 3.66
C21:0 1.26 1.62 2.12 1.76 2.29 0.48 1.50 0.80 0.08 3.38
C20:4 0.25 0.19 0.66 2.33 2.31 1.49 1.64 1.04 0.12 6.25
C22:0 1.82 1.91 2.41 2.24 0.11 - 0.52 - - 1.46
C24:0 6.39 7.03 7.93 9.17 8.00 - 3.50 5.07 - 13.51
C24:l 6.68 10.62 7.44 4.89 3.62 - 14.84 4.94 - 10.26
s/ua 1.22 1.46 2.27 2.10 2.02 1.83 1.20 1.59 1.16 1.10
Saturated to unsaturated fatty acid ratio.
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Blood samples were taken at three- to four-day 
intervals and separated into plasma and washed erythrocytes 
prior to total lipid extraction and separation of lipid 
classes.
Analyses of the plasma PL fraction (Figure 7, Table 6) 
showed that C18:0 and C18:2 comprised approximately 65 percent 
of the fatty acids. Changes in the percentage composition of 
C16:0 and C18:l tended to parallel one another. There appeared 
to be little correlation between the alterations in the major 
fatty acids of the PL fraction in plasma and the body tempera­
ture of the horse. There were no radical changes in the PL 
fraction of the plasma lipids until the disease became terminal. 
The saturated to unsaturated fatty acid ratio of the PL frac­
tion of the plasma throughout the disease was relatively stable?
only on day 20 did the percentages of saturated fatty acids
exceed those of the unsaturated fatty acids.
The FFA fraction (Table 7) of the plasma was composed 
chiefly of unsaturated fatty acids. At no time did the 
saturated fatty acid percentage composition exceed that of the 
unsaturated fatty acids of the FFA fraction of the plasma.
Seven days after infection C18:l decreased markedly while 
C18:3 and C21:0 had noticeable increases; however, by day 10 
all 3 of these fatty acids had returned to their normal ranges.
The major fatty acids of the TG fraction of the plasma
were C16:0, C16:l, C18:l, and C18:2 with C14:0, C18:0, and
C18:3 accounting for moderate percentages (Table 8 and Figure 
8). The data in Figure 8 demonstrated that C18:l, C18:2, and
Figure 7 Plots of body temperature and percent of 016:0, C16:l, C18:0, C18:l, and 
C18:2 of the fatty acids in the phospholipid class of plasma from Horse 
No. 6.
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Table 6. Percent of individual fatty acids of the phospholipid fraction from plasma of Horse No. 6
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17 20 23
C14:0 0.34 0.06 0.19 0.20 0.14 0.12 0.17
C16:0 9.99 15.53 12.71 8.49 11.98 15.28 18.39 19.84
C16:l 0.62 0.90 0.63 1.70 1.04 0.57 1.62 2.11
C18:0 34.42 27.63 28.93 31.41 29.38 30.24 32.61 27.74
C18:1 11.33 13.28 14.59 10.79 14.92 9.72 11.08 11.57
C18:2 35.76 38.11 36.53 40.02 40.20 40.12 32.58 36.27
C18:3 0.48 0.30 0.40 0.52 0.22 0.54 0.25 0.45
C20:0 0.51 0.50 0.67 0.37 0.08 0.18 0.31 0.28
C20:l 0.41 0.45 0.45 0.33 0.29 0.22 0.25 0.23
C21:0 0.35 0.18 0.28 0.31 0.19 0.08 0.06 -
C21:1 0.98 0.37 0.64 0.90 0.71 - - 0.31
C20:4 0.43 0.24 0.34 0.42 - 0.24 0.27 0.21
C22:0 0.31 0.18 0.63 0.41 - 0.11 0.17 . -
C22:l 0.72 0.48 1.15 0.78 - - 0.05 -
s/ua 0.90 0.81 0.79 0.74 0.72 0.89 1.12 0.93
a
Saturated to unsaturated fatty acid ratio.
Figure 8 Plots of body temperature and percent of C14:0, C16:0, C18:0, C18:l, and 
C18:2 of the fatty acids in the triglyceride class of plasma from Horse 
No. 6.
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Table 7. Percent of individual fatty acids of the free fatty acid 
fraction from plasma of Horse No. 6.
Fatty 
Ac id 3
Davs After 
7
Inoculation
10 14
C14:0 1.70 1.09 1.71 4.23
C16:0 12.08 6.42 20.73 16.69
C16:1 2.10 1.85 10.16 12.39
C18:0 16.37 3.13 16.84 7.11
C18:1 31.87 5.44 31.55 36.77
C18:2 25.39 19.81 10.10 11.23
C18:3 - 25.88 6.11 8.76
C20:0 1.58 2.92 0.07 0.09
C20:1 0 .28 2.44 0.38 0.35
C21:0 1.63 23.56 0.02 _ 0.03
C21:l 0.26 m 0.10 0.31
C20:4 0.14 6.06 - -
s/u a 0.55 0.60 0.67 0.40
aSaturated to unsaturated fatty acid ratio
i
Table 8. Percent of individual fatty acids of the triglyceride fraction from plasma of Horse No. 6.
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17 20 23
C14:0 2.63 2.53 2.52 1.56 2.26 2.64 1.24 1.87
C16:0 24.17 24.67 29.06 31.10 31.84 33.01 33.97 32.87
C16:1 6.36 4.00 3.45 11.61 10.83 11.62 13.65 8.54
C18:0 9.32 10.40 12.17 2.97 2.28 3.00 3.59 4.60
C18:l . 38.74 37.80 28.89 35.10 32.14 36.41 34.60 35.19
C18:2 10.13 14.50 17.05 9.37 8.66 3.42 6.66 8.66
C18:3 3.96 0.64 4.22 4.95 9.76 8.19 6.08 7.76
C20:0 0.10 3.20 0.16 0.04 0.23 0.24 Tra -
C20:l 0.76 0.11 0.49 0.29 0.07 0.06 0.20 -
C21:0 0.17 0.91 0.27 0.03 Tr Tr Tr
C21:l 0.36 0.38 0.3*8 0.19 0.18 0.26 Tr -
C20:4 - 0.36 - - - - -
C22:0
C22:l
s/ub 0.60 0.72 0.81
•
0.58
•
0.59 0.65 0.63 0.65
Trace amount.
Saturated to unsaturated fatty acid ratio
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C14:0 each had a tendency to exhibit a 3 peak area similar to 
that described by Gainer et al. (1966a). C18t0, which peaked
on the seventh day after inoculation, declined by the tenth 
day and remained depressed until the animal died on the 
twenty-third day. There appeared to be no correlation of 
fatty acid peaks with the temperature curve (Figure 8). The 
ratio of the saturated to unsaturated fatty acids in the TG 
fraction of the plasma appeared to be relatively stable.
The SE fraction of the plasma was primarily composed 
of C18:2. On the day of infection the concentration of C18:2 
was 73.73 percent and on day 7 it decreased to a low of 53.23 
percent of the fatty acids (Table 9 and Figure 9). The decrease 
in the concentration of C18:2 on day 7 was compensated for by 
increases in C18:l, C16:0, and C16:l as shown in Figure 9.
C18:l, C16:0, and C16:l remained elevated until death of the 
horse. The most impressive feature of the fatty acids in the 
SE fraction of the plasma was the relatively high concentration 
of unsaturated fatty acids. The ratio varied from 0.13 to 0.22, 
which was the lowest values for any of the lipid classes.
D. Analyses of the Lipid Classes of the Erythrocytes
The PL fraction of the erythrocytes constitutes about 
60 percent of the lipids of mammalian red blood cells 
(VanDeenen and DeGier, 1964). The PL fraction as seen in 
this study of horse erythrocytes was composed mainly of C16:0, 
C18:0, and C18:l. C16:0 decreased from 33.03 percent to
7.25 percent on day 3 after infection. The concentration of
Figure 9 Plots of body temperature and percent of C16:0, C16:l, C18:0, C18:l, and 
C18:2 of the fatty acids in the sterol ester class of plasma from Horse 
No. 6.
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Table 9. Percent of individual fatty acids of the sterol ester fraction from plasma of Horse No. 6.
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17 20 23
C14:0 0.64 0.52 0.91 0.56 0.61 0.71 0.61 0.61
C16:0 9.20 8.97 14.95 10.42 12.42 12.06 11.72 15.53
C16:1 3.07 2.83 4.41 3.29 5.20 5.42 5.09 8.02
C18:0 0.70 1.96 1.51 1.36 1.28 1.54 1.89 1.17
C18:l 10.11 13.23 22.83 11.31 13.72 11.46 11.22 13.19
C18:2 73.73 70,87 53.23 71.38 64.02 67.45 68.06 61.49
C18:3 0.24 0.23 0.46 0.62 0.63 0.69 0.47 -
C20:0 0.18 0.12 0.09 - - - - -
C20:1 0.18 0.03 0.18 - - 0.02 - m
C21:0 0.08 0.04 0.19 - 0.35 0.10 -
C21:l 0.21 0.26 0.04 0.19 0.14 0.11 -
C20:4 Tra - - - - - -
C22:0 0.35 - - - - - - m
C22:l - - - - - - -
C24:0 0.52 - - • m
s/ub 0.13 0.13 0.22 0.14 0.17 0.16 0.16 0.20
aTrace amount.
^Saturated to unsaturated fatty acid ratio.
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C16:0 increased by day 7 to 38.51 percent. A decrease in 
C16:0 occurred from day 14 to day 17. C18:0 and C18:l
followed the pattern of C16:0 from day 0 to day 14 (Figure 10). 
C18:l increased from day 14 to 39.08 percent and then decreased 
to 31.81 percent on day 20 only to again increase to 46.84 
percent on day 23 (Figure 10 and Table 10) . The concentration 
of C21:l, which usually was less than 5 percent, increased 
from 2.37 percent on day 0 to 20.91 percent 3 days after 
infection. However, by day 7 it decreased to less than 5 
percent and remained at this approximate level until just 
before death. The ratio of the saturated to unsaturated fatty 
acids had an initial value of 1.83 which first decreased and
then increased to 2.45 on day 7. The ratio then decreased 
on day 23 to 0.54. The principle reason for a ratio of 2.45 
on day 7 was the increase in the concentrations of C16:0 and 
the decrease in C21:l. The increase in C18:l and decrease in 
C18:0 on day 23 produced the ratio of 0.54 just prior to death.
The PFA fraction of the erythrocytes contained 34.50 
percent C16:0 on day 0. There were 2 peaks during the course 
of experimental EIA. The peaks occurred on day 3 and day 17 
when the concentrations were 46.19 percent and 51.02 percent, 
respectively. C16:0 had decreased to 23.86 percent on day 23 
(Figure 11 and Table 11). The concentration of C18:l remained 
relatively constant at approximately 17 percent until 14 days 
after infection. It decreased to 2.04 percent on day 17.
C18:l increased until death on day 23 to 51.09 percent. C18:2 
and C18:3 comprised a very low concentration of the FFA and
Figure 10. Plots of body temperature and percent of 016:0, C18:0, C18:l, and C21:l 
of the fatty acids in the phospholipid class of erythrocytes from Horse 
No. 6.
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Table 10. Percent of individual fatty acids of the phospholipid fraction from erythrocytes of Horse No. 6.
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17 20 23
C14:0 0.46 0.17 0.49 0.33 0.07 0.93 0.52 0.57
C16:0 33.03 7.25 38.51 34.57 27.15 10.50 23.69 25.98
C16:1 0.81 0.33 0.37 0.71 0.44 0.56 1.92 -
C18:0 24.93 6.28 22.86 26.11 20.86 30.57 24.71 0.27
C18:l 26.31 6.56 21.03 21.99 21.25 39.08 31.81 46.84
C18:2 1.15 0.29 0.82 0.80 1.85 2.64 2.11 1.85
C18:3 - 0.38 Tra 0.04 0.16 - - 0.15
C20:0 0.60 2.96 0.60 0.62 2.25 - 0.28 0.22
C20:l 0.51 1.52 0.60 0.62 0.32 - - 2.10
C21:0 1.48 6.47 1.11 1.35 3.22 - 1.41 5.89
C21:l 2.37 20.91 3.55 4.12 3.14 3.01 3.45 9.45
C20:4 0.59 5.02 0.99 0.86 1.61 - - 0.56
C22:0 0.59 3.00 4.01 2.64 0.56 11.10 2.69 -
C22:1 0.19 - 0.60 0.28 2.74 - -
C24:0 1.61 10.42 1.02 2.26 2.01 - 5.88 -
C24:l 0.25 - - - - - - -
C24:U1 2.04 — - — — — -
s/ub 1.83 1.04 2.45 2.30 1.78 1.17 1.50 0.54
STrace amount.
^Saturated to unsaturated fatty acid ratio.
Figure 11. Percent of C14:0# C16:0, C18:0, C18:l# and C18:2 of the fatty acids in the 
free fatty acid class of erythrocytes from Horse No. 6.
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Table 11. Percent of individual fatty acids of the free fatty acid fraction from erythrocytes of Horse
No. 6.
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17 20 23
C14:0 3.29 5.25 8.96 6.13 3.90 Tra 7.44 2.26
C16:0 34.50 46.19 40.05 35.27 38.57 51.02 34.74 23.86
C16:1 9.55 10.38 10.70 10.40 6.34 10.20 3.22 -
C18:0 9.43 14.44 13.93 16.09 22.67 16.33 20.68 14.30
C18:1 17.76 18.57 14.93 16.31 16.92 2.04 20.98 51.09
C18:2 0.66 - 0.19 - - Tr 1.19
C18:3 1.68 0.23 - 1.55 0.83 - -
C20:0 1.37 0.98 - 0.50 1.32 - - m
C20:l 1.55 0.69 1.24 0.19 0.20 - -
C21:0 0.54 0.52 0.75 - - - 0.63 0.40
C21:1 11.49 6.34 4.48 9.07 6.14 20.41 4.02 1.63
C20:4 0.84 0.81 - 0.53 - - - 0.17
C22:0 m 1.85 - - - - - 0.84
s/ub 1.12 1.87 2.03 1.51 2.18 2.06 2.24 0.77
a
Trace amount.
^Saturated to unsaturated fatty acid ratio.
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never represented more than 1.75 percent of the fatty acids 
throughout the course of disease. C21:l had an intial percen­
tage of 11.49, but by the first sampling period on day 3 it 
had dropped below its initial level (Figure 12). On day 17, 
C21:l increased to 20.41 percent only to decrease to below 
the initial level on day 20 and remain there until the horse 
died on day 23. Table 11 shows the ratio of saturated to 
unsaturated fatty acids. On day 23, the unsaturated fatty 
acids surpassed the saturated fatty acids in concentration.
This was primarily due to the relatively large increase in 
C18:l and the decrease in C16:0.
The major fatty acids of the TG fractions of the 
erythrocytes were C16:0 and C18:l (Table 12). The initial 
percentages for C16:0 and C18:l were 30 percent and 21 percent, 
respectively. Figures 13 and 14 show that C16:0 and C18:l 
reacted almost inversely until day 17. From day 17 until 
23 days after infection, the changes were almost identical. 
C18:0 maintained almost constant until day 17 when it 
Increased to about 26 percent; however, it had returned to 
its initial level by 23 days. The concentrations of C16:l 
and C14:0 were almost constant until day 17 when they 
decreased to less than 2 percent. By day 20 they had nearly 
returned to their initial levels. C21:l showed the most 
drastic change in concentration. On day 0 C21:l was present 
only in trace amounts but by day 17 it began to increase. On 
day 23, C21:l made up almost 39 percent of the fatty acids 
of the TG fraction of the erythrocytes (Table 12) .
Figure 12. Percent of C16:l, C18:3, and C21:l of the fatty acids in the free fatty 
acid class of erythrocytes from Horse No. 6.
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Figure 13. Plots of body temperature and percent of C14:0f C16:0, and C16:l of the
fatty acids in the triglyceride class of erythrocytes from Horse No. 6.
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Figure 14. Plots of body temperature and percent of C18:0, C18:l, and C21:l of the 
fatty acids in the triglyceride class of erythrocytes of Horse No. 6.
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Table 12. Percent of individual fatty acids of the triglyceride fraction from erythrocytes of Horse No. 6.
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17 20 23
C14:0 5.83 4.95 7.89 5.37 7.17 1.39 6.54 8.91
C16:0 30.69 34.06 36.27 23.94 35.06 5.89 27.04 9.62
C16:l 13.33 14.91 14.98 12.38 10.56 - 8.18 2.29
C18:0 7.64 5.37 6.55 7.60 5.78 26.00 13.09 6.02
C18:1 20.83 22.30 21.29 39.36 15.14 10.57 16.03 9.45
C18:2 1.81 2.19 1.38 0.54 1.20 0.52 2.62 0.93
C18:3 - 1.49 0.84 0.60 2.19 - 0.65 0.93
C20:0 0.42 0.29 0.30 0.33 - 26.00 1.53 -
C20:1 0.83 0.45 0.30 0.27 - 17.85 - -
C21:0 2.92 0.30 - - - 2.77
C21.-1 3.67 0.79 3.91 8.57 2.08 14.39 38.46
C20:4 - - - - - - - 1.10
C22:0 - - - - - . - 10.69
C22:1 - m ■* - - - - -
s/ua 1.29 0.99 1.30 0.65 1.27 1.91 1.15 0.72
Saturated to unsaturated fatty acid ratio.
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The SE fraction of the erythrocytes had the most even 
initial distribution of fatty acids (Figure 15 and 16 and 
Table 13). The concentrations of C18:0 and C18:l ranged 
between 12.82 percent and 14.87 percent on day 0. The con­
centrations of C16:0 and C18:0 increased on day 3 while C14:0 
and C16:l decreased. C18:0 was not found on day 7 while C16:0 
remained elevated to about 25 percent of the SE fraction. 
During this same period the concentrations of C14:0 and C16:l 
increased. All of the major fatty acids of the SE fraction 
subsequently underwent erratic fluctuations from day 10 until 
the animal's death at day 23. The saturated fatty acids made 
up a smaller percentage of the total SE lipid extract than 
the unsaturated fatty acids only on day 10 and day 23. The 
S/U of 0.46 on day 23 resulted from the appearance of an 
unknown C24 and an increase in C21:l (Table 13).
Additional supporting data of the fatty acid changes 
of total lipid extract from the plasma and erythrocytes of 
horses before and after inoculation with the EIA virus are 
presented in Tables 1 through 3 in the Appendix. Appendix 
Tables 4 through 7 represent the changes in the fatty acid 
of the PL, FFA, TG, and SE classes of plasma from Horse No. 4. 
Tables 8 through 11 represent the fatty acid changes in the 
PL, FFA, TG, and SE classes of erythrocytes from Horse No. 4. 
These additional supporting data have not been subjected to 
rhetoric in this dissertation since the trends of these data 
are similar.
Figure 15. Plots of body temperature and percent of C14:0, C16:0, and C16:l of the 
fatty acids in the sterol ester class of erythrocytes from Horse No. 6.
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Figure 16. Plots of body temperature and percent of 018:0, C18:l, and C21:l of the 
fatty acids in the sterol ester class of erythrocytes from Horse No. 6.
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Table 13. Percent of individual fatty acids of the sterol ester fraction from erythrocytes of Horse Ko. 6.
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17 20 23
C14:0 6.14 1.88 15.71 7.83 13.95 11.10 12.66 0.91
C16-.0 14.32 26.35 25.71 11.86 27.91 15.57 17.93 3.40
C16:l 12.82 6.87 25.71 9.62 12.56 16.84 6.22 0.13
C18:0 12.96 38.68 - 8.95 - 13.21 3.88 12.33
C18.-1 14.87 11.95 7.14 5.82 9.99 6.33 0.87
C18:2 0.41 - 5.71 5.15 - - 2.53 -
C18:3 0.68 - 7.14 6.71 - 1.05 - 17.50
C20:0 3.00 5.60 2.86 - 4.19 0.55 - -
C20:l 1.36 0.19 - - 1.86 0.44 4.43 0.29
C21:0 1.91 0.52 4.29 4.57 3.72 1.39 11.09 0.14
C21:1 7.09 1.51 - 5.15 9.77 5.27 6.01 19.41
C20:4 - 0.56 . - 4.03 2.79 1.33 3.16 18.07
C22:0 - 2.46 - 4.27 - 0.35
C24:0 - m - - - - - 13.33
C24:U1 - - m - - - 10.33
, a 
S/U 1.02 3.46 1,06 0.97;. 1.84 1.31 1.58 0.45
aSaturated to unsaturated fatty acid ratio. 
^Unknown saturated and/or branched C24 fatty acids.
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E* General Discussion of Data
The majority of the fatty acids in the total lipid 
extract from the plasma was composed of C18:2, C18:l, C16:0 
and C18:0. When TLC was employed to separate the lipid 
classes, the SE fraction and the PL fraction were found to 
contain higher percentages of C18:2 than the other fatty 
acids. Observations made of the TLC plates under ultraviolet 
light showed that the TG fraction made up an ever-increasing 
percentage of the total lipid extract from the plasma; the 
SE fraction steadily decreased in concentration as the disease 
progressed. The decline in C18:2 in the TG fraction, starting 
on day 7 (Figure 8) can be correlated to the decline of C18:2 
in the total lipid extract from the plasma (Figures 1 and 2). 
The increase of approximately 10 percent in C18:l in the total 
lipid extract from the plasma was found to be due to a slight 
increase in PL, FFA, TG, and SE fractions of the plasma. 
Although there was a slight decrease in the percentage of 
C18:l in the TG fraction, the marked increase in the total 
amount of this fraction resulted in the increase shown in 
C18:l (Figure 2).
The concentration of C16:0 fluctuated slightly in all 
lipid classes of the plasma except for the TG fraction. The 
TG fraction appeared to increase slowly and steadily by 
approximately 5 percent in C16:0 until just before the animal 
died (Figure 8). The increased fatty acids in the total lipid 
extract from plasma fluctuated similarly to the fatty acids in
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the PL, FFA, and SE classes. The increase in the percentage 
of C16:0 in the total lipid extract from plasma can be 
correlated to the increase of C16:0 in the TG fraction.
Analyses showed that there was a gradual increase in the 
concentration of C16:l in the total lipid extract and lipid 
classes during the course of EIA.
In the total lipid extract of erythrocytes, there was 
a marked decrease in the concentration of C16?0, C18:0, and 
C18:l 14 days after infection. The concentration returned 
to normal values by day 17 and remained normal until death.
When the lipid classes were analyzed, major decreases in 
C16:0 occurred in the TG fraction and the PL fraction at day 
17. Preinoculation values were attained 20 days after infec­
tion in the SE and PL fractions. The concentration of C18:0 
drastically decreased from day 20 to day 23.
The decrease in percentage composition in the total 
lipid extract from the plasma can be correlated to fluctuations 
in the concentrations of C18:l of the PL and SE fraction 
(Tables 1, 6, and 9).
The C24 fatty acids of unknown saturation and/or 
branching which appeared upon GLC analysis of the total lipid 
extracts from the erythrocytes were occasionally found in the 
PL and SE fractions when the fatty acids of the classes were 
chromatographed.
The data presented in this dissertation represent the 
changes in the various fatty acids of normal horses and horses 
which were experimentally infected with EIA from blood of a
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known carrier. These percentages should not be considered 
to be absolute values, as there are individual variations 
between animals (Tables 1, 3 and 4). The overall trend in 
fatty acid changes however, should be considered of major 
importance as individual animals exhibited different percen­
tage ranges of individual fatty acids.
Speculation on the mechanism of the anemia in EIA 
raises the following hypothesis. The experimentally produced 
anemia in this study is probably a dilutional type anemia 
quite similar to that reported by Westerman et al. (1970).
The marked increase in the concentration of lipids in blood 
acts as a diluent for the erythrocytes. In this investigation, 
horses died within 30 days of inoculation. Perhaps this 
short time period did not allow time for anemia to develop 
as a hemolytic anemia. Silver et al. (1964) believed that 
the hemolytic anemia which accompanied hyperlipemia was due 
to alterations of the erythrocyte membrane, which resulted 
in hemolysis. Silver et al. also stated that the degree of 
hemolysis could be directly correlated to the amount of liver 
damage as shown on liver function test and liver biopsy.
Westerman et al. (1970) reported that hemolytic anemia 
developed when the ratio of the plasma to red blood cell choles­
terol increased. Data obtained during this investigation 
showed that the overall levels of fatty acid in the SE fraction 
were relatively consistent. The SE fraction as observed on 
TLC plates decreased as the disease progressed. The SE fraction 
of the plasma proved to be very stable after an initial
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fluctuation, while the SE fraction of the erythrocytes 
exhibited greater fluctuations.
Westerman (1968) postulated that hemolytic anemia of 
Zieve's syndrome was due to the coating of erythrocytes with 
lipid. Data from this investigation certainly do not disprove 
this theory as similar hyperlipemic conditions exist in EIA.
Neerhout (1968) reported that humans with hyperlipemia
(
from liver damage had a marked alteration in the PL fraction 
of the erythrocytic lipids. The C16:0 and C18:l increased 
and the C18:0 decreased in human erythrocytes. Data from 
our experiments showed marked fluctuations in the fatty acids 
of the PL fraction and tended to support Neerhout's work. 
Neerhout stated that the hemolytic anemia was independent of 
the hyperlipemia and was a result of liver damage.
Calves infected with anaplasmosis experience severe 
anemias which probably result from surface alterations in 
the lipids of the circulating erythrocytes (Dimopoullos and 
Bedell, 1961, 1962, 1965; Dimopoullos, 1964). The data given 
here lends support to these findings, as there were alterations 
in the fatty acids of the PL and SE fractions from the erythro­
cytes. Such alterations or fluctuations in the erythrocytic 
membrane could also lead to the development of fragile membranes 
and intravascular hemolysis.
Bartley (1970) reported on the effects of fasting on 
normal horses. He found an increased lipid content in the 
blood plasma from the second to the eighteenth day. This 
increase was primarily due to the TG fraction. He made no
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mention of hemolytic anemia associated with this increased 
plasma lipid. Bartley's findings are identical to findings 
reported in fasting humans (Zawilaki and Paluszak, 1970).
Our experiment supports Bartley's data that the increase in 
lipid was due to the increase in the TG fraction, which was 
observed on TLC plates when the lipid classes were separated.
Gainer et al. (1966a) presented data on alterations 
of blood lipoprotein in horses infected with EIA. They 
reported that the temperature had a biphasic response. Horses 
in our experiments did not have a biphasic body temperature 
curve; however, several of the fatty acids (C16:0, C18:0 
and C18:l) from the total lipid extract of the erythrocytes 
showed a slight triphasic response which was similar to that 
reported by Gainer et al. Gainer et al. also proposed that 
the target area for the EIA virus in the horse was probably 
the hepatic cord cells.
The mode of action for hemolytic anemias have had 
numerous hypotheses. The list includes: alterations in the
erythrocytic membrane (McGuire et al., 1970), coating of 
erythrocytes with lipid (Westerman et al., 1968), alterations 
in the enzymatic reactions of the erythrocyte (Kaneko et al., 
1969), increased requirements of cellular energy (Kaneko et al., 
1969), abnormal lipids lysing erythrocytes (Blass and Dean,
1966), and unidentified effects produced by liver damage 
(Yamamoto and Koni, 1967).
Data in this dissertation lend support to the fact 
that alterations occur in the erythrocytic membrane. There
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were marked changes in one or more of the fatty acid concen­
trations in the PL, FFA, TG, and SE fractions of the erythro­
cytes. The marked lipemia experiences in EIA could certainly 
present the opportunity for coating the erythrocyte with lipid 
similar to Westerman's hypothesis that lipid coated erythro­
cytes have a decreased life span. Abnormal lipids in this 
study were confined to the long chain fatty acids. C24 fatty 
acids of unknown saturation and/or branching were present in 
the PL and SE fraction from the erythrocytes. This study 
does not prove that these unknown components are responsible 
for the hemolytic anemia of EIA.
This study lends credence that liver function is 
altered which results in the marked lipemia seen in EIA. It 
is possible that liver damage as suggested by Gainer et al. 
(1966a), and Yamamoto and Kono (1967) could be responsible 
for the hemolytic anemia of EIA, but additional research will 
be required to determine this mechanism of the anemia in EIA. 
Future research should explore the details of liver damage 
produced in EIA. The altered liver functions and the effect 
of these altered functions on the erythrocyte may lead to a 
better understanding of the hemolytic anemia of EIA.
SUMMARY AND CONCLUSIONS 
The plasma and erythrocytes of normal horses were 
subjected to lipid analysis to establish a normal base for 
the concentrations of fatty acids. These horses were inocu­
lated with blood from a known carrier of EIA virus. Blood 
samples taken at intervals were divided into plasma and 
erythrocytes and total lipids were extracted. The total 
lipid extracts were separated into lipid classes by TLC 
and the fatty acids analyzed by GLC.
The data obtained showed that the principle fatty 
acids of the plasma and erythrocytes were C16:0, C18:0, C18:l, 
C18:2, C18:3, C22:0, and C24:0.
The plasma was composed of a higher percentage of 
unsaturated fatty acids in all lipid classes while the 
erythrocytes had a higher percentage of saturated fatty acids. 
The erythrocytes also had a higher percentage of long chain 
fatty acids than did the plasma. The erythrocytes showed an 
increase in the percentage of C24 fatty acids as experimental 
EIA progressed. The data showed that these compounds were in 
the PL and SE fractions of the erythrocytes.
The total lipid extract of plasma was primarily 
composed of C18:2 in the normal horse. The C18:2 decreased 
as EIA progressed, and C18:l increased almost directly with
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the decreases in the C18:2. These data indicated that the 
major alterations in the fatty acids of the lipid extracts 
of the plasma began to take place 7 to 9 days after inocula­
tion. The SE fraction of plasma had a higher percentage of 
unsaturated fatty, acids than the other lipid classes.
The lipid extract from the erythrocytes exhibited 
extensive fluctuations in major fatty acids of all lipid 
classes in horses with EIA.
One of the primary purposes of this research was to 
determine if abnormal lipids were produced which could be 
responsible for the hemolytic anemia of EIA and possibly 
serve as a diagnostic aid. These data indicated the presence 
of an increasing concentration in the series of C24 fatty 
acids. This research did not prove that these fatty acids 
were responsible for the hemolytic anemia. This research 
yielded data which is similar to other studies which indicate 
that the severe lipemia which developed was due to liver 
changes.
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APPENDIX
Appendix Table 1. Percent of individual fatty acids of the total lipid extract from plasma of Horse No. 26.
Fatty
Acid
Davs Before Inoculation Davs After Inoculation
19 16 12 8 0 2 9 13 16 20 23 27 34 37
C14:0 0.60 0.69 0.59 0.62 0.62 0.69 0.95 0.58 0.58 0.61 0.57 0.39 1.09 2.22
C16:0 15.78 16.02 16.13 16.59 15.95 17.10 17.80 14.59 8.70 16.56 13.40 17.00 24.37 50.99
C16:1 3.09 2.78 2.03 2.30 1.88 2.33 4.70 3.03 2.86 2.06 1.99 1.72 6.80 4.97
C18-.0 19.33 18.06 18.14 17.23 19.00 18.55 7.74 20.06 22.81 19.85 18.21 17.39 12.16 24.34
C18:1 14.73 16.83 15.76 16.77 16.67 15.90 14.62 12.50 13.75 14.35 15.29 11.24 21.22 9.51
C18:2 41.32 42.06 44.15 45.16 41.69 42.80 52.25 46.27 48.34 44.81 46.74 48.15 18.33 5.41
C18:3 0.87 1.36 0.81. 0.88 0.77 1.20 0.24 1.56 1.50 1.15 1.46 1.01 8.99 0.51
C20:0 0.65 0.24 0.33 0.18 0.91 0.21 - 0.22 0.19 - 0.37 0.41 1.18 -
C20:1 0.27 0.11 0.29 - 0.41 0.25 - 0.09 0.11 — 0.31 0.21 - -
s/ua 0.60 0.56 0.56 0.53 0.59 0.58 0.37 0.56 0.48 0.59 0.49 0.56 0.57 3.80
a
Saturated to unsaturated fatty acid ratio.
Appendix Table 2. Percent of individual fatty acids of the total lipid extract from plasma of Horse No. 12.
Fatty
Acid
Davs Before Inoculation Davs After Inoculation
50 48 46 43 41 7 4 0 3 7 10 14 20
C14:0 0.66 0.45 0.99 0.81 0.45 0.79 0.99 0.38 0.89 1.16 2.05 1.33 2.14
C16:0 15.49 11.24 21.36 16.36 12.91 15.58 22.87 15.62 21.83 30.45 13.36 29.49 29.18
C16:1 2.05 1.60 2.22 2.17 2.08 2.64 3.85 0.62 3.56 4.84 4.72 4.48 4.59
C18-.0 17.42 13.81 13.59 17.08 22.81 12.47 11.61 14.46 9.80 9.79 15.14 9.30 11.85
C18:1 13.34 10.23 14.83 14.52 11.76 16.21 17.17 10.61 14.70 22.67 12.74 25.13 22.98
C18:2 47.00 56.46 43.01 43.80 43.61 46.75 35.47 55.27 44.43 22.57 37.14 20.70 20.16
C18:3 1.64 1.39 1.46 2.37 1.85 2.55 4.11 1.54 0.22 6.65 2.19 7.44 5.74
C20:0 0.40 2.36 0.15 0.37 0.40 Tra 0.27 0.50 0.33 0.12 1.16 0.21 Tr
C20:1 0.24 0.18 0.19 0.44 0.29 Tr 0.32 Tr 0.22 0.16 Tr 0.26 Tr
C20:2 0.21 0.15 0.17 0.26 0.18 0.26 0.23 0.38 Tr 0.02 Tr Tr Tr
s/ub 0.52 0.40 0.58 0.54 0.61 0.42 0.58 0.45 0.52 0.73 0.56 0.70 0.81
a
Trace amount.
b
Saturated to unsaturated fatty acid ratio.
Appendix Table 3. Percent of individual fatty acids of the total lipid extract from erythrocytes of Horse
No. 14.
Fatty
Acid
Davs Before Inoculation Davs After Inoculation
48 11 7 4 0 3 7 10 14 17 20
C14:0 1.00 0.80 m aTr 0.89 8.75 1.30 0.55 0.63 0.89 0.99 0.58
C16:0 22.72 26.43 16.50 24.77 24.11 29.50 20.71 23.32 21.51 26.00 23.65
C16:l 3.16 1.97 1.71 2.93 1.27 5.30 2.01 2.57 4.95 3.32 2.92
C18:0 26.61 21.65 38.84 22.00 21.95 23.80 19.34 23.34 19.13 24.05 21.21
C18:1 28.41 25.47 36.29 15.17 19.11 21.60 14.65 23.18 19.81 25.54 22.27
C18:2 4.34 0.76 0.15 0.70 0.11 1.30 1.30 1.42 0.99 1.99 2.32
C18:3 2.58 Tr ' 1.16 Tr Tr Tr Tr Tr Tr Tr Tr
C20:0 Tr 2.16 3.36 2.68 2.16 1.80 1.35 1.72 1.10 1.55 1.43
C20:1 Tr 2.48 - 1.90 3.18 0.40 0.20 0.42 0.18 0.45 0.48
C21:l Tr 2.35 Tr Tr 2.10 1.30 2.55 3.28 2.44 2.91 1.70
C20:4 Tr 0.50 Tr Tr 0.32 1.30 1.89 0.05 1.24 1.17 0.53
C22:Q Tr 1.97 1.99 2.60 2.39 1.80 0.99 1.18 6.60 Tr 1.11
C24:0 Tr 9.05 - 16.78 9.03 8.40 4.69 5.12 1.77 4.17 4.14
C24:U1 - 2.03 - 4.82 2.78 2.20 16.88 1.14 Tr 1.30 Tr
C24:U2 - - - - - - 10.20 10.12 11.60 5.04 15.54
s/ub 1.31 1.75 1.54 2.73 2.37 1.99 0.96 1.31 1.24 1.36 1.14
a
Trace amount.
Saturated to unsaturated fatty acid ratio.
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Appendix Table 4. Percent of individual fatty acids of the phospholipid
fraction from plasma of Horse No. 4.
Fatty
Acid
Davs After Inoculation
3 10 14 17
C14:0 0.26 0.15 0.20 0.43
C16:0 5.96 9.07 18.82 14.15
C16:1 0.74 0.92 1.05 1.36
C18:0 35.42 40.44 30.21 26.94
C18:1 9.00 4.43 10.49 11.87
C18: 2 44.03 37.86 33.89 32.27
C18:3 0.46 0.41 0.45 1.16
C20:0 0.44 0.37 0.48 0.83
C20:1 0.48 0.33 0.48 0.45
C21:0 0.29 0.31 0.19 0.32
C21:1 0.92 0.98 0.81 -
C20:4 0.07 1.73 0.26 0.74
C22:0 0.20 0.11 0.34
G22:1 0.02 0.85 0.13
s/ua 0.76 1.08 1.03 0.89
a
Saturated to unsaturated fatty acid ratio.
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Appendix Table 5. Percent of individual fatty acids of the free fatty
acid fraction from plasma of Horse No. 4.
Fatty
Acid
Davs After Inoculation
0 3 10 17
C14:0 2.89 2.49 1.85 1.65
C16:0 22.42 24.96 23.59 28.55
C16:1 - 7.09 10.28 12.13
C18:0 21.72 11.86 6.12 5.18
C18:1 29.39 26.32 37.46 35.00
C18:2 2.84 16.19 10.28 7.73
C18:3 0.24 4.73 8.62 6.60
C20:0 5.21 0.27 0.19 0.07
C20:1 6.40 0.33 0.48 0.25
C21:0 3.78 - - 0.45
C21:1 4.14 1.57 m -
C24:0 - 0.42 - 0.20
s/ua 1.30 0.71 0.47 0.58
A
Saturated to unsaturated fatty acid ratio.
t
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Appendix Table 6. Percent of individual fatty acids of the triglyceride
fraction from plasma of Horse No. 4.
Fatty
Acid . . 7
Davs After Inoculation 
10 17
C14.-0 2.00 1.78 6.40
C16-.0 31.06 32.26 14.48
C16:1 7.11 9.74 12.64
C18:0 8.72 34.50 7.30
C18:1 31.89 8.72 38.61
C18:2. 15.39 7.81 9.75
C18:3 4.33 0.18 0.04
C20:0 0.06 0.11 8.65
C20:1 0.28 0.24 0.04
C21:0 0.11 - 0.80
C21:1 0.11 - -
C20:4 0.28 - -
C22:0
C22:1
. a S/U 0.71 2.57 0.62
a
Saturated to unsaturated fatty acid ratio.
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Appendix Table 7. Percent of individual fatty acids of the sterol ester
fraction from plasma of Horse No. 4.
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17
C14:0 0.56 0.41
I
0.39 1.18 2.24 0.47
C16:0 6.21 9.54 8.76 15.71 43.12 12.70
C16:1 1.98 2.95 2.70 5.45 0.17 5.83
C18:0 6.21 1.22 1.34 2.12 35.19 10.15
C18:1 6.21 5.05 11.26 16.23 8.22 68.72
C18: 2 5.46 78.64 74.03 52.23 8.76 0.36
C18:3 43.91 0.31 0.17 0.40 0.02 -
C20:0 10.40 0.11 0.26 0.04 0.29 0.13
C20:1 9.34 - 0.29 0.66 - -
C21:0 - 0.23 "!• 0.22 0.23 0.15
C21:1 5.59 - - - - -
C20:4 - 0.26 0.10 0.03 -
C22:0 - - - - -
G22:1 — “ -
s/ua 0.32 0.13 0.12 0.25 4.71 0.31
Saturated to unsaturated fatty acid ratio.
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Appendix Table 8. Percent of individual fatty acids of the phospholipid
fraction from erythrocytes of Horse No. 4.
Fatty
Acid
JDavs After Inoculation
0 3 7 . 10 14 17
C14:0 0.27 0.62 0.42 0.29 0.42
C16:0 13.28 36.80 35.09 23.06 17.84 20.53
C16:1 0.59 0.86 1.07 1.85 1.28 2.58
C18:0 11.62 22.44 19.92 20.12 15.05 27.31
C18:1 61.85 26.31 22.02 19.85 17.22 28.91
C18: 2 0.34 0.60 1.43 1.35 22.90 3.00
C18:3 0.08 - 0.05 1.84 1.88 0.11
C20:0 0.77 1.38 0.86 4.04 1.23 0.78
C20:1 0.61 0.86 0.74 9.17 3.17 0.53
C21:0 1.58 2.58 2.71 0.17 0.34 1.11
C21:1 2.16 1.72 3.14 0.80 - 3.62
C20:4 0.43 1.38 0.80 1.13 2.23 0.44
C22:0 0.61 - 4.45 4.30 4.18 2.71
C22:1 0.61 - 1.89 0.97 1.36 1.24
C24:0 - 4.13 2.41 m - 2.91
C24:U1 2.37 1.37
s/ua 0.41 2.12 2.12 1.41 0.78 1.37
£
Saturated to unsaturated fatty acid ratio.
Appendix Table 9. Percent of individual fatty acids of the free fatty
acid fraction from erythrocytes of Horse No. 4.
Fatty
Acid
Davs After Inoculation
3 7 10 14 17
C14:0 8.29 5.90 4.62 1.60 39.91
C16:0 36.26 34.99 31.68 13.67 28.82
C16:1 7.82 7.50 1.76 2.20 2.22
C18:0 14.22 15.76 21.34 7.60 6.65
C18:1 18.13 19.16 25.08 8.55 11.09
C18:2 6.04 0.87 1.54 1.29 -
C18:3 m 0.27 0.44 50.66 -
C20:0 - 0.97 0.44 - m
C20:1 0.59 0.87 0.77 - -
C21:0 m ' 0.33 0.22 1.33 0.22
C21:1 2.49 5.16 5.39 - 1.55
C20:4 - 1.10 1.41 0.67
C22:0 «■ - MB 0.53 • -
C22-.1 “ - m 9.53 -
s/ua 1.68 1.66 1.67 0.23 4.87
a
Saturated to unsaturated fatty acid ratio.
92
Appendix Table 10. Percent of individual fatty acids of the triglyceride
fraction from erythrocytes of Horse No. 4.
Fatty
Acid
Davs After Inoculation
0 3 7 10 14 17
C14:0 10.37 5.78 4.88 5.39 9.48 4.71
C16:0 26.85 25.05 28.17 27.75 30.82 27.99
C16:1 7.01 2.00 6.50 12.33 11.03 13.73
C18:0 14.03 12.49 10.83 12.14 13.28 11.31
C18:1 7.09 40.58 29.25 22.16 17.59 23.01
C18:2 3.10 4.51 6.50 4.82 2.50 1.75
C18:3 2.65 0.33 - 1.93 0.26 0.27
C20:0 0.51 0.23 0.49 1.35 0.60 1.21
C20:1 0.16 0.60 0.98 0.96 0.30 0.27
C21:0 - - 0.60 5.39 0.34 4.44
C21-.1 7.01 1.70 1.35 - 0.26 -
C20:4 - - 0.54 - 0.82 -
s/ua 1.99 0.88 1.00 1.23 1.66 1.27
a
Saturated to unsaturated fatty acid ratio.
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Appendix Table 11. Percent of individual fatty acids of the sterol ester
fraction from erythrocytes of Horse No.4.
Fatty
Acid
Days Aftar Inoculation
0 3 7 ' 10 14
C14:0 3.51 10.90 5.61 5.86 2.93
C16:0 6.59 25.00 11.45 24.92 16.70
C16-.1 10.51 9.62 7.88 11.73 16.27
C18:0 2.41 2.88 2.69 2.12 10.09
C18:1 3.18 6.09 4.15 10.67 10.70
C18:2 14.23 12.02 3.37 5.54 2.14
C18:3 2.11 5.45 1.46 3.50 3.12
C20:0 9.92 2.08 1.57 1.79 3.61
C20:1 - - 1.57 2.85 1.65
C21-.0 - - - 4.15 2.75
C21:1 - - - 2.85 4.40
C20:4 7.86 - 1.01 2.44 1.65
C22:0 4.72
C24:1
, a 
S/U 0.71 1.23 1.09 0.98 0.90
a
Saturated to unsaturated fatty acid ratio.
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